Allergan plc
AGN
AGN was delisted on the 8th of May, 2020.
1,105 hedge funds and large institutions have $74.7B invested in Allergan plc in 2016 Q3 according to their latest regulatory filings, with 98 funds opening new positions, 432 increasing their positions, 456 reducing their positions, and 88 closing their positions.
11% more first-time investments, than exits
New positions opened: 98 | Existing positions closed: 88
0% less funds holding
Funds holding: 1,107 → 1,105 (-2)
5% less repeat investments, than reductions
Existing positions increased: 432 | Existing positions reduced: 456
5% less capital invested
Capital invested by funds: $79B → $74.7B (-$4.31B)
7% less funds holding in top 10
Funds holding in top 10: 115 → 107 (-8)
15% less call options, than puts
Call options by funds: $3.45B | Put options by funds: $4.07B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$797M |
| 2 |
State Street
Boston,
Massachusetts
|
+$764M |
| 3 |
Lazard Asset Management
New York
|
+$288M |
| 4 |
Jennison Associates
New York
|
+$215M |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
+$174M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$943M |
| 2 |
IC
Icahn Carl
Sunny Isles Beach,
Florida
|
-$727M |
| 3 |
GE
General Electric
Evendale,
Ohio
|
-$619M |
| 4 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$492M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$448M |
AGN Hedge Fund Activity: Q3 2016 in Review
1,105 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2016, worth a combined $74.7B — down 5.5% from $79B a quarter earlier.
Buyers outnumbered sellers: 98 funds opened new AGN positions and 88 closed out — a net gain of 10 holders — while 432 added to existing stakes and 456 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $797M. The largest seller was T. Rowe Price Associates, cutting an estimated $943M.
- 1,105 institutional investors held Allergan plc (AGN) as of Q3 2016, down from 1,107 in Q2 2016.
- Funds reported $74.7B of Allergan plc stock for Q3 2016, down 5.5% quarter-over-quarter.
- 98 funds opened new Allergan plc positions in Q3 2016 and 88 closed out, a net change of +10 holders.
- The largest Allergan plc buyer in Q3 2016 was Fidelity Investments, an estimated $797M added.
- The largest Allergan plc seller in Q3 2016 was T. Rowe Price Associates, an estimated $943M sold.
Based on aggregated 13F filings for Q3 2016.